BCR-ABL 1 Kinase Domain Mutation Analysis (Irma)
1
Leukemia
This test detects ABL Kinase mutations that may lead to imatinib resistance, including the important T315I and P-loop mutations.
What is this test?
A range of levels of resistance and prognosis has been observed for different mutations. ABL kinase domain mutations that cause only moderate resistance may be overcome by higher imatinib doses.
BCR-ABL 1 Kinase Domain Mutation Analysis (Irma) is offered as a lab test. Follow preparation instructions if any, and consult your doctor to interpret results.
Test Included (1) Parameters
- BCR-ABL1 Kinase Domain Mutation Analysis
Preparation Required
Drink water to stay hydrated
Continue regular medication unless advised
Inform phlebotomist if pregnant
Fast for 12 hours before sample collection
How it Works
- Select Test: Choose a lab test or add more tests/packages.
- Pick Collection Slot: Select a time and address for home sample collection.
- Sample Collected & Reports Delivered: Reports will be available online within 24 hours.